Table 3.
Perioperative and short-term outcomes
| Outcome | All (N = 72) | MVR (N = 56) | H-TMVR (N = 16) | P |
|---|---|---|---|---|
| Valve embolization, n (%) | 2 (2.78%) | 0 (0%) | 2 (12.50%) | .007 |
| AV groove disruption, n (%) | 1 (1.39%) | 0 (0%) | 1 (6.25%) | .059 |
| LCX injury, n (%) | 0 (0%) | 0 (0%) | 0 (0%) | - |
| LVOTO, n (%) | 3 (4.17%) | 0 (0%) | 3 (18.75%) | .001 |
| Second valve placement, n (%) | 2 (2.78%) | 0 (0%) | 2 (13%) | .007 |
| Procedure conversion, n (%) | 1 (1.39%) | 0 (0%) | 1 (6.25%) | .059 |
| IABP, n (%) | 2 (2.78%) | 0 (0%) | 2 (12.50%) | .007 |
| PVL moderate+, n (%) | 2 (2.78%) | 1 (1.79%) | 1 (6.25%) | .338 |
| Valve reintervention, n (%) | 0 (0.00%) | 0 (0%) | 0 (0.00%) | - |
| Stroke, n (%) | 3 (4.17%) | 3 (5.36%) | 0 (0.00%) | .344 |
| New RRT, n (%) | 5 (6.94%) | 3 (5.36%) | 2 (12.50%) | .322 |
| Reoperation for bleed, n (%) | 2 (2.78%) | 1 (1.79%) | 1 (6.25%) | .338 |
| DSWI, n (%) | 2 (2.78%) | 0 (0%) | 2 (13%) | .007 |
| In-hospital mortality, n (%) | 6 (8.33%) | 2 (3.57%) | 4 (25.00%) | .006 |
| 1-y survival, % (95% CI) | 76% (87.63%-64.63%) | 82.82% (94.96%-70.68%) | 54.69% (80.43%-28.95%) | .004 |
| Hospital LOS, median (Interquartile range) | 10.5 (9-15.5) | 10.5 (9-15) | 10.5 (7.5-24.5) | .469 |
| ICU LOS, median (Interquartile range) | 2.0 (4-7) | 2.0 (4-6) | 3.0 (7-10.25) | .992 |
MVR, Mitral valve replacement; H-TMVR, hybrid transcatheter mitral valve replacement; AV, atrioventricular; LCX, left circumflex; LVOTO, left ventricular outflow tract obstruction; IABP, intra-aortic balloon pump; PVL, paravalvular leak; RRT, renal replacement therapy; DSWI, deep sternal wound infection; CI, confidence interval; LOS, length of stay; ICU, intensive care unit.